<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35192678</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>BEX1 is a critical determinant of viral myocarditis.</ArticleTitle><Pagination><StartPage>e1010342</StartPage><MedlinePgn>e1010342</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1010342</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1010342</ELocationID><Abstract><AbstractText>Viral infection of the heart is a common but underappreciated cause of heart failure. Viruses can cause direct cardiac damage by lysing infected cardiomyocytes. Inflammatory immune responses that limit viral replication can also indirectly cause damage during infection, making regulatory factors that fine-tune these responses particularly important. Identifying and understanding these factors that regulate cardiac immune responses during infection will be essential for developing targeted treatments for virus-associated heart failure. Our laboratory has discovered Brain Expressed X-linked protein 1 (BEX1) as a novel stress-regulated pro-inflammatory factor in the heart. Here we report that BEX1 plays a cardioprotective role in the heart during viral infection. Specifically, we adopted genetic gain- and loss-of-function strategies to modulate BEX1 expression in the heart in the context of coxsackievirus B3 (CVB3)-induced cardiomyopathy and found that BEX1 limits viral replication in cardiomyocytes. Interestingly, despite the greater viral load observed in mice lacking BEX1, inflammatory immune cell recruitment in the mouse heart was profoundly impaired in the absence of BEX1. Overall, the absence of BEX1 accelerated CVB3-driven heart failure and pathologic heart remodeling. This result suggests that limiting inflammatory cell recruitment has detrimental consequences for the heart during viral infections. Conversely, transgenic mice overexpressing BEX1 in cardiomyocytes revealed the efficacy of BEX1 for counteracting viral replication in the heart in vivo. We also found that BEX1 retains its antiviral role in isolated cells. Indeed, BEX1 was necessary and sufficient to counteract viral replication in both isolated primary cardiomyocytes and mouse embryonic fibroblasts suggesting a broader applicability of BEX1 as antiviral agent that extended to viruses other than CVB3, including Influenza A and Sendai virus. Mechanistically, BEX1 regulated interferon beta (IFN-&#x3b2;) expression in infected cells. Overall, our study suggests a multifaceted role of BEX1 in the cardiac antiviral immune response.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martens</LastName><ForeName>Colton R</ForeName><Initials>CR</Initials><Identifier Source="ORCID">0000-0002-8692-6992</Identifier><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorn</LastName><ForeName>Lisa E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kenney</LastName><ForeName>Adam D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Institute, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bansal</LastName><ForeName>Shyam S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yount</LastName><ForeName>Jacob S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Institute, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Accornero</LastName><ForeName>Federica</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-1209-7228</Identifier><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Institute, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AI151230</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F30 HL145955</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL154001</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL136951</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI165391</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI130110</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>22</Day><Hour>17</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35192678</ArticleId><ArticleId IdType="pmc">PMC8896894</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1010342</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-21-01646</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>K&#xfc;hl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, et al.. High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With &#x201c;Idiopathic&#x201d; Left Ventricular Dysfunction. Circulation. 2005;111(7):887&#x2013;93. doi: 10.1161/01.CIR.0000155616.07901.35</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000155616.07901.35</ArticleId><ArticleId IdType="pubmed">15699250</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, et al.. Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction. Circulation. 2005;112(13):1965&#x2013;70. doi: 10.1161/CIRCULATIONAHA.105.548156</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.548156</ArticleId><ArticleId IdType="pubmed">16172268</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumori A, Kawai C. Experimental animal models of viral myocarditis. European Heart Journal. 1987;8(suppl_J):383&#x2013;8. doi: 10.1253/jcj.51.1362</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/jcj.51.1362</ArticleId><ArticleId IdType="pubmed">2832629</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward C. Severe arrhythmias in Coxsackievirus B3 myopericarditis. Archives of disease in childhood. 1978;53(2):174&#x2013;6. doi: 10.1136/adc.53.2.174</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.53.2.174</ArticleId><ArticleId IdType="pmc">PMC1545349</ArticleId><ArticleId IdType="pubmed">646424</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose NR. Autoimmunity in Coxsackievirus Infection. Group B Coxsackieviruses. Berlin, Heidelberg: Springer Berlin Heidelberg; 2008. p. 293&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">18357776</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearney MT, Cotton JM, Richardson PJ, Shah AM. Viral myocarditis and dilated cardiomyopathy: mechanisms, manifestations, and management. Postgraduate Medical Journal. 2001;77(903):4. doi: 10.1136/pmj.77.903.4</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pmj.77.903.4</ArticleId><ArticleId IdType="pmc">PMC1741887</ArticleId><ArticleId IdType="pubmed">11123385</ArticleId></ArticleIdList></Reference><Reference><Citation>Olejniczak M, Schwartz M, Webber E, Shaffer A, Perry TE. Viral Myocarditis&#x2014;Incidence, Diagnosis and Management. Journal of Cardiothoracic and Vascular Anesthesia. 2020. doi: 10.1053/j.jvca.2019.12.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2019.12.052</ArticleId><ArticleId IdType="pubmed">32127272</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenney AD, McMichael TM, Imas A, Chesarino NM, Zhang L, Dorn LE, et al.. IFITM3 protects the heart during influenza virus infection. Proceedings of the National Academy of Sciences. 2019;116(37):18607. doi: 10.1073/pnas.1900784116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1900784116</ArticleId><ArticleId IdType="pmc">PMC6744864</ArticleId><ArticleId IdType="pubmed">31451661</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054&#x2013;62. doi: 10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Peter P, Mason Jay W. Advances in the Understanding of Myocarditis. Circulation. 2001;104(9):1076&#x2013;82. doi: 10.1161/hc3401.095198</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc3401.095198</ArticleId><ArticleId IdType="pubmed">11524405</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzum M, Ruppert V, K&#xfc;ytz B, Jomaa H, Nakamura I, Maisch B. Coxsackievirus B3 Infection Leads to Cell Death of Cardiac Myocytes. Journal of Molecular and Cellular Cardiology. 1994;26(7):907&#x2013;13. doi: 10.1006/jmcc.1994.1108</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmcc.1994.1108</ArticleId><ArticleId IdType="pubmed">7966359</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow LH, Beisel KW, McManus BM. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab Invest. 1992;66(1):24&#x2013;31. .</Citation><ArticleIdList><ArticleId IdType="pubmed">1309927</ArticleId></ArticleIdList></Reference><Reference><Citation>McManus BM, Chow LH, Wilson JE, Anderson DR, Gulizia JM, Gauntt CJ, et al.. Direct Myocardial Injury by Enterovirus: A Central Role in the Evolution of Murine Myocarditis. Clinical Immunology and Immunopathology. 1993;68(2):159&#x2013;69. doi: 10.1006/clin.1993.1113</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/clin.1993.1113</ArticleId><ArticleId IdType="pubmed">7689428</ArticleId></ArticleIdList></Reference><Reference><Citation>Henke A, Huber S, Stelzner A, Whitton JL. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. Journal of Virology. 1995;69(11):6720. doi: 10.1128/JVI.69.11.6720-6728.1995</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.11.6720-6728.1995</ArticleId><ArticleId IdType="pmc">PMC189582</ArticleId><ArticleId IdType="pubmed">7474082</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Yusung S, Frisancho S, Barrett M, Gatewood S, Steele R, et al.. IL-12 Receptor &#x3b2;1 and Toll-Like Receptor 4 Increase IL-1&#x3b2;- and IL-18-Associated Myocarditis and Coxsackievirus Replication. The Journal of Immunology. 2003;170(9):4731. doi: 10.4049/jimmunol.170.9.4731</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.9.4731</ArticleId><ArticleId IdType="pubmed">12707353</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafilou K, Orthopoulos G, Vakakis E, Ahmed MA, Golenbock DT, Lepper PM, et al.. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell Microbiol. 2005;7(8):1117&#x2013;26. Epub 2005/07/13. doi: 10.1111/j.1462-5822.2005.00537.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2005.00537.x</ArticleId><ArticleId IdType="pubmed">16008579</ArticleId></ArticleIdList></Reference><Reference><Citation>Young LHY, Joag SV, Zheng LM, Young JDE, Lee CP, Lee YS. Perforin-mediated myocardial damage in acute myocarditis. The Lancet. 1990;336(8722):1019&#x2013;21. doi: 10.1016/0140-6736(90)92486-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(90)92486-2</ArticleId><ArticleId IdType="pubmed">1699101</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, Job LP, Woodruff JF. Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes. The American journal of pathology. 1980;98(3):681&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1903528</ArticleId><ArticleId IdType="pubmed">6244737</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman NM, Kim KS. Persistent Coxsackievirus Infection: Enterovirus Persistence in Chronic Myocarditis and Dilated Cardiomyopathy. Group B Coxsackieviruses. Berlin, Heidelberg: Springer Berlin Heidelberg; 2008. p. 275&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">18357775</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hl U, Pauschinger M, Schwimmbeck Peter L, Seeberg B, Lober C, Noutsias M, et al.. Interferon-&#x3b2; Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction. Circulation. 2003;107(22):2793&#x2013;8. doi: 10.1161/01.CIR.0000072766.67150.51</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000072766.67150.51</ArticleId><ArticleId IdType="pubmed">12771005</ArticleId></ArticleIdList></Reference><Reference><Citation>Accornero F, Schips TG, Petrosino JM, Gu S-Q, Kanisicak O, van Berlo JH, et al.. BEX1 is an RNA-dependent mediator of cardiomyopathy. Nature Communications. 2017;8(1):1875. doi: 10.1038/s41467-017-02005-1 Accornero2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02005-1</ArticleId><ArticleId IdType="pmc">PMC5709413</ArticleId><ArticleId IdType="pubmed">29192139</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams JW, Hawes SM, Patel B, Latham KE. Trophectoderm-specific expression of the X-linked Bex1/Rex3 gene in preimplantation stage mouse embryos. Mol Reprod Dev. 2002;61(3):281&#x2013;7. Epub 2002/02/09. doi: 10.1002/mrd.10100 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrd.10100</ArticleId><ArticleId IdType="pubmed">11835573</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilar M, Murillo-Carretero M, Mira H, Magnusson K, Besset V, Ibanez CF. Bex1, a novel interactor of the p75 neurotrophin receptor, links neurotrophin signaling to the cell cycle. Embo j. 2006;25(6):1219&#x2013;30. Epub 2006/02/25. doi: 10.1038/sj.emboj.7601017 ; PubMed Central PMCID: PMC1422154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7601017</ArticleId><ArticleId IdType="pmc">PMC1422154</ArticleId><ArticleId IdType="pubmed">16498402</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C, Wang JH, Yue F, Kuang S. The brain expressed x-linked gene 1 (Bex1) regulates myoblast fusion. Dev Biol. 2016;409(1):16&#x2013;25. Epub 2015/11/21. doi: 10.1016/j.ydbio.2015.11.007 ; PubMed Central PMCID: PMC4688182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2015.11.007</ArticleId><ArticleId IdType="pmc">PMC4688182</ArticleId><ArticleId IdType="pubmed">26586200</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo JH, Smiley MA, Lovering RM, Margolis FL. Bex1 knock out mice show altered skeletal muscle regeneration. Biochem Biophys Res Commun. 2007;363(2):405&#x2013;10. Epub 2007/09/22. doi: 10.1016/j.bbrc.2007.08.186 ; PubMed Central PMCID: PMC2265538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2007.08.186</ArticleId><ArticleId IdType="pmc">PMC2265538</ArticleId><ArticleId IdType="pubmed">17884015</ArticleId></ArticleIdList></Reference><Reference><Citation>Covarrubias R, Ismahil MA, Rokosh G, Hamid T, Accornero F, Singh H, et al.. Optimized protocols for isolation, fixation, and flow cytometric characterization of leukocytes in ischemic hearts. American Journal of Physiology-Heart and Circulatory Physiology. 2019;317(3):H658&#x2013;H66. doi: 10.1152/ajpheart.00137.2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00137.2019</ArticleId><ArticleId IdType="pmc">PMC6766726</ArticleId><ArticleId IdType="pubmed">31373510</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorn Lisa E, Lasman L, Chen J, Xu X, Hund Thomas J, Medvedovic M, et al.. The N6-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy. Circulation. 2019;139(4):533&#x2013;45. doi: 10.1161/CIRCULATIONAHA.118.036146</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.036146</ArticleId><ArticleId IdType="pmc">PMC6340720</ArticleId><ArticleId IdType="pubmed">30586742</ArticleId></ArticleIdList></Reference><Reference><Citation>Baksi AJ, Kanaganayagam GS, Prasad SK. Arrhythmias in Viral Myocarditis and Pericarditis. Cardiac Electrophysiology Clinics. 2015;7(2):269&#x2013;81. doi: 10.1016/j.ccep.2015.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccep.2015.03.009</ArticleId><ArticleId IdType="pubmed">26002391</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai WS, Carballo E, Strum JR, Kennington EA, Phillips RS, Blackshear PJ. Evidence that Tristetraprolin Binds to AU-Rich Elements and Promotes the Deadenylation and Destabilization of Tumor Necrosis Factor Alpha mRNA. Molecular and Cellular Biology. 1999;19(6):4311. doi: 10.1128/MCB.19.6.4311</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.19.6.4311</ArticleId><ArticleId IdType="pmc">PMC104391</ArticleId><ArticleId IdType="pubmed">10330172</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean JLE, Wait R, Mahtani KR, Sully G, Clark AR, Saklatvala J. The 3&#x2032; Untranslated Region of Tumor Necrosis Factor Alpha mRNA Is a Target of the mRNA-Stabilizing Factor HuR. Molecular and Cellular Biology. 2001;21(3):721. doi: 10.1128/MCB.21.3.721-730.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.21.3.721-730.2001</ArticleId><ArticleId IdType="pmc">PMC86664</ArticleId><ArticleId IdType="pubmed">11154260</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreau C, Paillard L, Osborne HB. AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res. 2005;33(22):7138&#x2013;50. Epub 2006/01/05. doi: 10.1093/nar/gki1012 ; PubMed Central PMCID: PMC1325018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki1012</ArticleId><ArticleId IdType="pmc">PMC1325018</ArticleId><ArticleId IdType="pubmed">16391004</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda K, Ripley B, Nishimura R, Mino T, Takeuchi O, Shioi G, et al.. Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo. Proceedings of the National Academy of Sciences. 2013;110(23):9409. doi: 10.1073/pnas.1307419110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1307419110</ArticleId><ArticleId IdType="pmc">PMC3677444</ArticleId><ArticleId IdType="pubmed">23676272</ArticleId></ArticleIdList></Reference><Reference><Citation>Seko Y, Takahashi N, Yagita H, Okumura K, Yazaki Y. Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus B3. The Journal of Pathology. 1999;183(1):105&#x2013;8. doi: 10.1002/(SICI)1096-9896(199709)183:1&amp;lt;105::AID-PATH1094&amp;gt;3.0.CO;2-E</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9896(199709)183:1&amp;lt;105::AID-PATH1094&amp;gt;3.0.CO;2-E</ArticleId><ArticleId IdType="pubmed">9370955</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J-X, Su X, Xu J, Zhang W-Y, Shi Y. HuR post-transcriptionally regulates TNF-&#x3b1;-induced IL-6 expression in human pulmonary microvascular endothelial cells mainly via tristetraprolin. Respiratory Physiology &amp; Neurobiology. 2012;181(2):154&#x2013;61. doi: 10.1016/j.resp.2012.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2012.02.011</ArticleId><ArticleId IdType="pubmed">22426177</ArticleId></ArticleIdList></Reference><Reference><Citation>Past&#xe9; M, Huez G, Kruys V. Deadenylation of interferon-&#x3b2; mRNA is mediated by both the AU-rich element in the 3&#x2032;-untranslated region and an instability sequence in the coding region. European Journal of Biochemistry. 2003;270(7):1590&#x2013;7. doi: 10.1046/j.1432-1033.2003.03530.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1432-1033.2003.03530.x</ArticleId><ArticleId IdType="pubmed">12654014</ArticleId></ArticleIdList></Reference><Reference><Citation>do Amaral MJ, Araujo TS, D&#xed;az NC, Accornero F, Polycarpo CR, Cordeiro Y, Cabral KMS, Almeida MS. Phase Separation and Disorder-to-Order Transition of Human Brain Expressed X-Linked 3 (hBEX3) in the Presence of Small Fragments of tRNA. J Mol Biol. 2020. Mar 27;432(7):2319&#x2013;2348. doi: 10.1016/j.jmb.2020.02.030 Epub 2020 Mar 3. .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2020.02.030</ArticleId><ArticleId IdType="pubmed">32142787</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewek J, Kaczmarek K, Cygankiewicz I, Wranicz JK, Ptaszynski P. Inflammation and arrhythmias: potential mechanisms and clinical implications. Expert Review of Cardiovascular Therapy. 2014;12(9):1077&#x2013;85. doi: 10.1586/14779072.2014.942286</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14779072.2014.942286</ArticleId><ArticleId IdType="pubmed">25060800</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal SS, Ismahil MA, Goel M, Patel B, Hamid T, Rokosh G, et al.. Activated T Lymphocytes are Essential Drivers of Pathological Remodeling in Ischemic Heart Failure. Circulation: Heart Failure. 2017;10(1941&#x2013;3297 (Electronic)). doi: 10.1161/CIRCHEARTFAILURE.116.003688</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.116.003688</ArticleId><ArticleId IdType="pmc">PMC5331621</ArticleId><ArticleId IdType="pubmed">28242779</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishida K, Otsu K. Inflammation and metabolic cardiomyopathy. Cardiovascular Research. 2017;113(4):389&#x2013;98. doi: 10.1093/cvr/cvx012</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvx012</ArticleId><ArticleId IdType="pubmed">28395010</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Frangogiannis NG. The role of inflammatory and fibrogenic pathways in heart failure associated with aging. Heart Failure Reviews. 2010;15(5):415&#x2013;22. doi: 10.1007/s10741-010-9161-y Chen2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-010-9161-y</ArticleId><ArticleId IdType="pmc">PMC2920375</ArticleId><ArticleId IdType="pubmed">20213186</ArticleId></ArticleIdList></Reference><Reference><Citation>Swirski FK, Nahrendorf M. Cardioimmunology: the immune system in cardiac homeostasis and disease. Nature Reviews Immunology. 2018;18(12):733&#x2013;44. doi: 10.1038/s41577-018-0065-8 Swirski2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0065-8</ArticleId><ArticleId IdType="pubmed">30228378</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>